Relexxii Tablet, Extended Release
Product Images NDC 68025-088

17 FDA label images from Vertical Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Relexxii (NDC 68025-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vertical Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Relexxii Structural Formula (Relexxii Methylphenidate Hydrochloride Extended Re 1)

Relexxii Structural Formula (Relexxii Methylphenidate Hydrochloride Extended Re 1)
Chemical structure of methylphenidate hydrochloride, the active ingredient in RELEXXII. The diagram shows the molecular configuration including a piperidine ring and phenyl group with associated functional groups.*
FDA Label Image

Figure 1 (Relexxii Methylphenidate Hydrochloride Extended Re 2)

Figure 1 (Relexxii Methylphenidate Hydrochloride Extended Re 2)
A line graph comparing mean plasma methylphenidate concentration (ng/mL) over time (hours) between methylphenidate HCl extended-release tablets 18 mg once daily and methylphenidate 5 mg taken three times daily. The graph shows plasma concentration trends from 0 to 32 hours, illustrating the pharmacokinetic profiles of the two dosing regimens.*
FDA Label Image

Figure 2 (Relexxii Methylphenidate Hydrochloride Extended Re 3)

Figure 2 (Relexxii Methylphenidate Hydrochloride Extended Re 3)
A bar chart comparing maximum symptoms of inattention/overactivity scale between methylphenidate hydrochloride extended-release tablets once daily and placebo across three studies. Each study shows symptom levels with black bars for the drug and white bars for placebo, indicating lower symptom scores with methylphenidate hydrochloride in all studies including Study 3 at Week 4.*
FDA Label Image

Figure 3 (Relexxii Methylphenidate Hydrochloride Extended Re 4)

Figure 3 (Relexxii Methylphenidate Hydrochloride Extended Re 4)
A line graph comparing attention levels over 12 hours post initial dose between methylphenidate hydrochloride extended-release tablets and placebo. The vertical axis measures combined attention on a scale where lower values indicate more attentive. Two lines show methylphenidate and placebo groups, with methylphenidate consistently showing better attention. Sample sizes and error bars are included.*
FDA Label Image

Vertical Logo (Relexxii Methylphenidate Hydrochloride Extended Re 5)

FDA Label Image

Vertical Logo (Relexxii Methylphenidate Hydrochloride Extended Re 6)

FDA Label Image

Relexxii 18 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 7)

Relexxii 18 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 7)
Label for RELEXXII 45 mg extended-release tablets, methylphenidate hydrochloride. The label includes dosage strength, quantity of 30 tablets, manufacturer details (Vertical Pharmaceuticals, LLC), and storage instructions. It states the product is prescription only and includes a barcode with the NDC 68025-088-30.*
FDA Label Image

Relexxii 18 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 8)

Relexxii 18 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 8)
Label for RELEXXII 45 mg extended-release tablets containing methylphenidate hydrochloride. The label includes dosage form, strength, manufacturer Vertical Pharmaceuticals, LLC, a barcode, and storage instructions. The package contains 100 tablets and is prescription only.*
FDA Label Image

Relexxii 27 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 9)

Relexxii 27 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 9)
Label for RELEXXII 63 mg extended-release tablets containing methylphenidate hydrochloride. The label includes dosage strength, NDC 68025-089-30, a barcode, and packaging details. It indicates the product is dispensed by Vertical Pharmaceuticals, LLC in Alpharetta, GA, contains 30 tablets, and is for prescription use only.*
FDA Label Image

Relexxii 27 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 10)

Relexxii 27 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 10)
RELEXXII 63 mg extended-release tablets labeled for oral use containing methylphenidate hydrochloride. The label includes dosage strength (63 mg), packaging quantity (100 tablets), and distributor information (Vertical Pharmaceuticals, LLC, Alpharetta, GA). Storage instructions note keeping the package child-resistant and storing at 20° to 25°C. The label also features the NDC 68025-089-10 and a barcode.*
FDA Label Image

Relexxii 36 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 11)

Relexxii 36 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 11)
Label for RELEXXII methylphenidate hydrochloride extended-release tablets, 36 mg strength. The label states the product contains 36 mg methylphenidate hydrochloride per tablet and includes dosing and storage instructions. Marketed by Vertical Pharmaceuticals, LLC. Package size is 100 tablets, Rx only.*
FDA Label Image

Relexxii 36 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 12)

Relexxii 36 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 12)
Label for RELEXXII 36 mg extended-release tablets containing methylphenidate hydrochloride. The label states it is a human prescription drug, with 30 tablets per bottle. It includes storage instructions, child-resistant packaging information, barcode, and is distributed by Vertical Pharmaceuticals, LLC, Alpharetta, GA.*
FDA Label Image

Relexxii 45 mg 30ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 13)

Relexxii 45 mg 30ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 13)
Label for RELEXXII 45 mg extended-release tablets containing methylphenidate hydrochloride. The label shows the National Drug Code (NDC) 68025-088-30, indicates that it is an oral human prescription drug available in a bottle of 30 tablets. Manufactured and distributed by Vertical Pharmaceuticals, LLC, Alpharetta, GA. The label includes storage instructions and a warning to keep out of reach of children.*
FDA Label Image

Relexxii 54 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 14)

Relexxii 54 mg 100ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 14)
Label for RELEXXII 54 mg extended-release tablets containing methylphenidate hydrochloride. The label shows it is marketed by Vertical Pharmaceuticals, LLC and includes storage instructions, a child-resistant package notice, and a barcode. The package contains 100 tablets, marked Rx Only.*
FDA Label Image

Relexxii 54 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 15)

Relexxii 54 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 15)
Label for RELEXXII 54 mg extended-release tablets containing methylphenidate hydrochloride. The label shows the drug name, strength, dosage form, and manufacturer Vertical Pharmaceuticals, LLC. It also displays storage instructions, child-resistant packaging notice, quantity of 30 tablets, and a barcode with NDC 68025-098-30.*
FDA Label Image

Relexxii 63 mg 30ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 16)

Relexxii 63 mg 30ct Bottle Label (Relexxii Methylphenidate Hydrochloride Extended Re 16)
Label for RELEXXII 63 mg extended-release tablets containing methylphenidate hydrochloride, distributed by Vertical Pharmaceuticals, LLC. The label includes dosage form, strength, a note on storage conditions, packaging count of 30 tablets, and that it is prescription only. It also features the NDC 68025-089-30 and a barcode.*
FDA Label Image

Relexxii 72 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 17)

Relexxii 72 mg 30ct Bl (Relexxii Methylphenidate Hydrochloride Extended Re 17)
Label for RELEXXII 72 mg extended-release tablets containing methylphenidate hydrochloride. The label includes storage instructions, a note to dispense with accompanying medication guide, and indicates the package contains 30 tablets. The product is distributed by Vertical Pharmaceuticals, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.